OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Economics
181 Publications
found
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis.
b
Journal of neurology, neurosurgery, and psychiatry
December 1, 2021
p
Newborn Screening
c
Economics
Model
Costs and Consequences of Eliminating a Routine, Point-Of-Care HIV Screening Program in a High-Prevalence Jail.
b
American journal of preventive medicine
November 1, 2021
p
HIV POCT
c
Economics
Model
Lifetime Cost Effectiveness of Phenylketonuria Screening National Program in Iran.
b
Iranian journal of public health
October 1, 2021
p
Newborn Screening
c
Economics
Model
Cost-effectiveness of precision diagnostic testing for precision medicine approaches against non-small-cell lung cancer: A systematic review.
b
Molecular oncology
October 1, 2021
p
Cancer
c
Economics
Review
Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data.
b
International journal of neonatal screening
September 15, 2021
p
Newborn Screening
c
Economics
Model
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
b
BMC cancer
September 1, 2021
p
Cancer
c
Economics
Review
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.
b
Rheumatology and therapy
September 1, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
RCT
Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn’s disease patients: A cost-effectiveness analysis.
b
Journal of gastroenterology and hepatology
September 1, 2021
p
Therapeutic drug monitoring
c
Economics
Model
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn’s Disease.
b
The American journal of gastroenterology
August 1, 2021
p
Inflammatory Bowel Disease
c
Clinical outcomes
Economics
Highlighted
Model
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease.
b
Applied health economics and health policy
July 1, 2021
p
Inflammatory Bowel Disease
c
Clinical outcomes
Economics
Model
Previous Page
1
…
3
4
5
6
7
…
19
Next Page
